isobarbaloin

isobarbaloin的基本解释

-

[医] 异芦荟甙

与isobarbaloin相关的网络例句 [注：此内容来源于网络，仅供参考]

Aloin and Isobarbaloin are major activity for anthraquinone derivative in Aloe. It's hydrolysis to aloe-emodin-9-anthrone, and oxidant to aloe-emodin at intestine bacteria.

芦荟大黄苷及异芦荟大黄苷是芦荟之蒽醌类衍生物的主要有效成分，经肠内细菌作用，水解成芦荟大黄素-9-蒽酮，再氧化成芦荟大黄素，而产生泻下作用。

After IV administration of Aloin and Isobarbaloin mixture solution to six rabbits, the plasma level-time profiles of Aloin and Isobarbaloin were adequately described by an open two-compartment model.

六只家兔於试验设计下，进行指标成分混合液在不同剂量静脉给药试验，结果显示芦荟大黄苷及异芦荟大黄苷在家兔体内之经时浓度变化，初步呈现二室开放模式的趋势。

The high-performace liquid chromatographic method was developed for determination of Aloin and Isobarbaloin in rabbit blood. A HPLC system equipment, a Merk LiChrospher 100 RP-18e column with the mobile phase consisted of methanol-water (50:50) and UV detection wavelength at 359nm. The internal standard was 7-hydroxycoumarin and follow rate was 1.0ml/min.

并首先开发出在家兔体内血浆中二个指标成分之高效液相层析分析法，使用Merk LiChrospher 100 RP-18为层析管柱，移动相为甲醇与水（50：50），内部标准品为7-羟基香豆素，在检测波长359nm，流速1.0 ml/min下，分别定量血浆检品与进行确效性的评估。

At the IV dose of 20 and 30 mg/kg, Aloin and Isobarbaloin result appear the mean terminal eliminate half-life（T1/2 β）were 54.1±28.4; 28.7±18.3 and 36.9±21.9;49.7±17.1 min, respectively. The mean area under the serum concentration curve（AUC0-∞）were about 411.655± 13.027;318.213±19.924 and 701.336±116.631;573.278± 86.870μg min/mL, respectively. The mean drug clearancewere 0.165±0.011;0.214±0.016 and 0.149±0.030;0.182±0.035 L/min, respectively.

若静脉注射剂量20和30 mg/kg后，其芦荟大黄苷及异芦荟大黄苷分别平均末端排除半衰期（T1/2 β）为54.1±28.4；28.7±18.3和36.9±21.9；49.7±17.1 min，平均稳定状态分布体积为7.668±3.155；6.343±3.522和5.146±2.490；8.525±2.683 L，平均曲线下面积（AUC0-∞）为411.655 ±13.027；318.213±19.924 和701.336±116.631；573.278±86.870 μgmin/mL，平均血浆中药物最高浓度为23.920±5.669；30.442 ±7.537和57.920±27.690；36.373±14.174 μg/mL，平均药物之清除率为0.165±0.011；0.214±0.016和0.149±0.030；0.182±0.035 L/min。

At the IV dose of 20 and 30 mg/kg, Aloin and Isobarbaloin result appear the mean terminal eliminate half-life（T1/2 β）were 54.1±28.4; 28.7±18.3 and 36.9±21.9;49.7±17.1 min, respectively. The mean area under the serum concentration curve（AUC0-∞）were about 411.655± 13.027;318.213±19.924 and 701.336±116.631;573.278± 86.870μgE min/mL, respectively. The mean drug clearancewere 0.165±0.011;0.214±0.016 and 0.149±0.030;0.182±0.035 L/min, respectively.

若静脉注射剂量20和30 mg/kg后，其芦荟大黄苷及异芦荟大黄苷分别平均末端排除半衰期（T1/2 β）为54.1±28.4；28.7±18.3和36.9±21.9；49.7±17.1 min，平均稳定状态分布体积为7.668±3.155；6.343±3.522和5.146±2.490；8.525±2.683 L，平均曲线下面积（AUC0-∞）为411.655 ±13.027；318.213±19.924 和701.336±116.631；573.278±86.870 μgEmin/mL，平均血浆中药物最高浓度为23.920±5.669；30.442 ±7.537和57.920±27.690；36.373±14.174 μg/mL，平均药物之清除率为0.165±0.011；0.214±0.016和0.149±0.030；0.182±0.035 L/min。

与isobarbaloin相关的网络解释 [注：此内容来源于网络，仅供参考]

anthranol：蒽酚

芦荟泻素蒽酚或芦荟泻素蒽酮,芦荟大黄素甙的异构体异芦荟大黄素甙(Isobarbaloin),高塔尔芦荟素(Homonataloin),大黄酚(Chrysophanol),大黄酚葡萄糖甙(Chrysophanolglucoside),蒽酚(Anthranol)等蒽类及其甙类,以及榭皮素(Quercetin),

Barbaloin：芦荟苷

老芦荟含芦荟总苷约25%,其中以芦荟苷(barbaloin)为主. 此外,还有少量异芦荟苷(isobarbaloin)和芦荟大黄素(aloeemodin)以及芦荟树脂等. 新芦荟含芦荟苷约9%以及芦荟树脂等成分,而异芦荟苷含量甚微,或基本不含.